美国新生儿死亡率的差异
Ibrahim Qattea1,2, Maria Burdjalov3, Amani Quatei1
1Department of Neonatalogy, Cleveland Clinic Children's, 9500 Euclid Avenue #M31-37, Cleveland, OH 44195, USA.
Children (Basel, Switzerland)
|August 26, 2023
概括
新生儿死亡率仍然高于黑人婴儿比白人婴儿,尽管总体下降. 这些差异仍然存在于各种人口和医院因素中.
科学领域:
- 公共卫生 公共卫生
- 新生儿医学 新生儿医学
- 健康差距 研究 研究 研究 研究
背景情况:
- 新生儿死亡率是婴儿健康的关键指标.
- 现有研究表明,婴儿死亡率存在种族差异.
研究的目的:
- 为了比较黑色和白色新生儿之间的新生儿死亡率.
- 分析各种流行病学和医院因素之间的这些差异.
主要方法:
- 使用了2012-2018年国家住院样本 (NIS) 数据集.
- 包括所有美国医院的长达28天的新生儿.
- 分析了诸如种族,收入,保险,医院类型和地理区域等因素.
主要成果:
- 黑人新生儿的死亡率比白人新生儿的死亡率高 (0.63%) (0.28%).
- 黑人新生儿更有可能拥有政府保险和较低的家庭收入.
- 根据美国人口普查部门的死亡率有很大差异,黑人新生儿的死亡率在各个阶层中始终较高.
结论:
- 在黑人和白人人口之间,新生儿死亡率仍然存在显著差异.
- 这些差异在多种人口和医院相关因素中是显而易见的.
- 需要进一步的研究和有针对性的干预措施来解决这些不平等问题.
相关概念视频
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...


